Edwards Lifesciences (EW) Tops Q4 EPS by 4c, Offers Guidance
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $87.36 +0.78%
EPS Growth %: +10.4%
Financial Fact:
Provision for income taxes: 43.8M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +10.4%
Financial Fact:
Provision for income taxes: 43.8M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.59, $0.04 better than the analyst estimate of $0.55. Revenue for the quarter came in at $1.39 billion versus the consensus estimate of $1.36 billion.
GUIDANCE:
Edwards Lifesciences sees Q1 2025 EPS of $0.58-$0.64, versus the consensus of $0.59. Edwards Lifesciences sees Q1 2025 revenue of $1.35-1.43 billion, versus the consensus of $1.36 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
- Wall Street scrambles to lift Micron price targets ahead of earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
